Found 0 matching trials
Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects
PHASE1This trial is conducted in the United States of America (USA). The aim of t...
Location
Novo Nordisk Investigational Site
SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity
PHASE3The study looks at how liraglutide works on participant's body weight. Rese...
Status
Active Not Recruiting
Location
TMC Hlthcr Clin Res Office
Liraglutide Effects on Epicardial Fat Inflammatory Genes
PHASE4Epicardial adipose tissue (EAT) is the visceral fat of the heart. EAT could...
Location
University of Miami
GLP-1 REceptor Agonists and Real World EvIdeNce
N/AGlucagon-like peptide-1 receptor agonists (GLP-1RA) are powerful second-lin...
Location
Servizio di Diabetologia UOC Medicina Generale
Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects
PHASE4The aim of this study is to explore the effectiveness of liraglutide combin...
Location
The Third Affiliated Hospital of Sun Yat-sen University
Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers
PHASE1This trial is conducted in Europe. the aim of this trial is to compare the ...
Location
Novo Nordisk Investigational Site
Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat
PHASE4The purpose of this research study is to learn about the effect of Liraglut...
Location
Multiple Locations
PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome
PHASE4The purpose of this study was to determine whether monotherapy treatment wi...
Location
University Medical Center Ljubljana
Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health
N/AThis study is investigating the effect of a medication called glucagon-like...
Location
Guy's and St Thomas' NHS Foundation Trust
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
PHASE4BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Location
Unit of Endocrinology and Metabolic Diseases